%0 Journal Article %T ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy %A Akiva Mintz %A Benjamin Ellingson %A Daniel Barboriak %A Daniel Kim %A David Mankoff %A Elizabeth R. Gerstner %A Erin Greco %A Eva-Maria Ratai %A Gregory Sorensen %A James Fink %A Kathleen Schmainda %A Lale Kostakoglu %A Lucy Hanna %A Mark Muzi %A Melissa Prah %A Ovidiu C. Andronesi %A Todd Richards %A Zheng Zhang %A on behalf of the ACRIN 6684 trial group %J Archive of "PLoS ONE". %D 2018 %R 10.1371/journal.pone.0198548 %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002091/